Erratum: Author Correction: Pyridoxine dipharmacophore derivatives as potent glucokinase activators for the treatment of type 2 diabetes mellitus (Scientific reports (2017) 7 1 (16072))
dc.contributor.author | Dzyurkevich M.S. | |
dc.contributor.author | Babkov D.A. | |
dc.contributor.author | Shtyrlin N.V. | |
dc.contributor.author | Mayka O.Y. | |
dc.contributor.author | Iksanova A.G. | |
dc.contributor.author | Vassiliev P.M. | |
dc.contributor.author | Balakin K.V. | |
dc.contributor.author | Spasov A.A. | |
dc.contributor.author | Tarasov V.V. | |
dc.contributor.author | Barreto G. | |
dc.contributor.author | Shtyrlin Y.G. | |
dc.contributor.author | Aliev G. | |
dc.date.accessioned | 2020-09-02T22:16:45Z | |
dc.date.available | 2020-09-02T22:16:45Z | |
dc.date.issued | 2018 | |
dc.identifier | 10.1038/s41598-018-24838-6 | |
dc.identifier.citation | 8, 1, 6489- | |
dc.identifier.issn | 20452322 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12728/4323 | |
dc.description | A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper. | |
dc.language.iso | en | |
dc.publisher | NLM (Medline) | |
dc.title | Erratum: Author Correction: Pyridoxine dipharmacophore derivatives as potent glucokinase activators for the treatment of type 2 diabetes mellitus (Scientific reports (2017) 7 1 (16072)) | |
dc.type | Erratum |